TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Wai Yuen Tong Medicine Holdings Limited ( (HK:0897) ).
Wai Yuen Tong Medicine Holdings Limited has announced a board meeting scheduled for November 24, 2025, to discuss and approve the interim results for the six months ending September 30, 2025, and to consider the payment of an interim dividend. This meeting is significant as it will provide insights into the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
The most recent analyst rating on (HK:0897) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Wai Yuen Tong Medicine Holdings Limited stock, see the HK:0897 Stock Forecast page.
More about Wai Yuen Tong Medicine Holdings Limited
Wai Yuen Tong Medicine Holdings Limited is a company incorporated in Bermuda, primarily operating in the pharmaceutical industry. The company is known for its production and distribution of traditional Chinese medicine and healthcare products.
Average Trading Volume: 1,161,135
Technical Sentiment Signal: Buy
Current Market Cap: HK$489.4M
Find detailed analytics on 0897 stock on TipRanks’ Stock Analysis page.